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Background: Recurrent respiratory papillomatosis (RRP) is a rare disease, which is characterised by the growth of
papillomavirus-induced papillomas within the respiratory tract. Malignant transformation occurs in less than 1% of
the cases.
Case presentation: We report a case of human papillomavirus (HPV) type 11-associated juvenile-onset RRP (JORRP)
initially diagnosed at the age of two years. Remarkably high copy numbers of HPV11 DNA and antibody titres
targeting the capsid protein L1 were detected in the patient’s serum. The patient developed squamous cell
carcinomas in both lungs and extraordinarily an HPV11 DNA-positive papillary endocardial lesion in the left atrium
of the heart, which caused thromboembolic events leading to the patient’s death at 19 years old.
Conclusion: We here report a severe case of JORRP hallmarked by HPV11 DNAemia and very high antibody titres
directed against the major viral capsid protein L1. Furthermore, the extent of malignant transformation and the
discovery of a very rare fatal endocardial lesion highlight the unpredictability of JORRP and the complexity of its
clinical management.
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Juvenile onset recurrent respiratory papillomatosis (JORRP)
is a relatively rare disease, but still the most common
pediatric neoplasm found in the larynx. Papillomas gener-
ally appear in the larynx of children before the age of five
and recur after surgical excision in a majority of cases. Only
5% of the patients show involvement of trachea and bron-
chi and 1% of patients will develop manifestations within
the lung parenchyma [1,2]. Rarely, spontaneous carcin-
omatous transformation occurs [3]. Generally, distant me-
tastases do not occur [2]. Clinical and epidemiological
studies have determined that HPV is the etiological agent* Correspondence: Thomas.Iftner@med.uni-tuebingen.de
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unless otherwise stated.of JORRP [4,5] with HPV6 and 11 accounting for
most cases. Most reports of JORRP-associated squamous
cell carcinomas of the lung, in which an HPV type was de-
termined, describe male patients with HPV11-associated
JORRP [3,6-11].
Here we describe a 19-year-old male patient with an
aggressive form of JORRP that required a total of 132
interventions within the 17 years following diagnosis.Case presentation
A 14 year old male patient was referred to the Department
of Otolaryngology, Head and Neck Surgery at the Univer-
sity Hospital Tuebingen in August 2002. Diagnosed at the
age of two he underwent tracheostomy and since had been
treated for juvenile onset recurrent respiratory papilloma-
tosis (JORRP) through multiple surgeries. Papillomas were
detectable in the larynx, trachea, and main bronchi andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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time of referral the patient had already undergone 116
operations. A total of 16 surgical excisions and laser
ablations were performed during the following 5 years. In
addition to ablative therapies, the patient was treated
with the antiviral drug cidofovir for three years (2004–
2007): first intralesionally, later systemically and finally via
inhalations.
At the age of 18, he presented with a tracheal stenosis
that was treated by balloon dilatation; he was also af-
fected by pneumothorax and subcutaneous emphysema
of his upper body, which was treated by a thoracic
drainage. One year later the patient developed symptoms
of Leriche’s syndrome caused by thromboembolic occlu-
sion of the aortoiliac bifurcation. An embolectomy was
performed. Additional thromboembolic events caused
minor infarctions in both kidneys and the spleen. An
ischemic stroke in the supply area of the left middle
cerebral artery caused aphasia, hemiparesis and facial
nerve paresis. Four days later, another thromboembolic
crisis led to an occlusion of both femoral arteries. Mag-
netic resonance imaging revealed a suspicious mass in
the left cardiac atrium, involving the right pulmonary
vein. About one month later a series of thromboembolic
events involving the brain, liver, heart, kidneys, aorta,
and pelvic arteries occurred. The patient finally died and
an autopsy was performed at the Institute of Pathology,
University Hospital Tuebingen.
Association of the patient’s disease with HPV11
To characterise the patient’s viral infection in more
detail, DNA was extracted from surgically removed laryn-
geal papillomas. Exclusively HPV11 DNA was detected in
the specimens and qRT-PCR (see Additional file 1) esti-
mated the viral genome copy number as 1.2 × 104 copies/
cell. These viral load values are suggestive of a productive
infection at the larynx. A full length HPV11 genome was
isolated from a laryngeal papilloma and completely se-
quenced. The genome was 99% identical to the prototype
sequence [12] (NCBI number: M14119), with a total of 27
nucleotide deviations. Fifteen of which did not result in
amino acid substitutions in the respective proteins. Three
mutations, one deletion and three nucleotide insertions
occurred in the Long Control Region. The remaining
five mutations affected the amino acid sequence of viralTable 1 Detected amino acid changes within the isolated HPV





3991 G Cproteins (Table 1), however, the analysis of the protein
sequences revealed that these mutations do not occur in
conserved or functional domains and most probably do
not interfere with the proteins’ activities.
Patient’s blood samples were investigated for the pres-
ence of HPV11 (Table 2). Total DNA was extracted from
200 μl of whole blood, plasma, leukocyte and erythrocyte
fractions. HPV11 DNA was only detected in whole
blood and the plasma fraction but not in any of the cel-
lular fractions. qRT-PCR determined that 8.85 × 105 viral
genome copies/ml were present in the whole blood and
1.55 × 106 viral genome copies/ml were measured within
the plasma fraction. These data suggest that most viral
genomes were not cell associated, which was supported
by the data obtained by measuring the viral load within
the filtered plasma fraction (0.2 μm filters), where all
possible residual cells were eliminated, and 5.61 × 105
viral genome copies/ml remained. As a way of indirectly
demonstrating the presence of viral particles, plasma
samples were treated with Benzonase in order to digest
all unencapsidated DNA. Benzonase treatment has pre-
viously been reported to be both effective and safe for
the elimination of free viral DNA from papillomavirus
suspensions [13]. Our results indicate that probably no
viral particles were present within the patient’s plasma
samples (Table 3).
The patient’s immune-response against HPV was deter-
mined in blood samples from August 2005 and April
2007. In 2005 a significant response to the major capsid
protein L1 of HPV11 was present with about 3,000
median fluorescence units (MFI) at a dilution of 1:100.
The antibody response increased further to 30,000 MFI in
the 2007 sample indicating a more than 10-fold increase
in titre. No antibodies against HPV11 E6 and E7 were
detected.
Autopsy findings
Post mortem examinations revealed that the patient
presented with a papillomatous neoplasia of the trachea
and main bronchi with what appeared to be microinvasive
growth (Figure 1A). Canalicular dissemination within the
respiratory tree had occurred. Notably, all pulmonary
lobes were affected by multiple confluent well-differenti-
ated squamous cell carcinomas (Figure 1B) with minor
foci of keratinisation (Figure 1C) and focal necrosis,11 genome
d change Affected amino acid Affected viral protein
Ala 45→ Ser 45 E7
Arg 318→ Ala 318 E1
Lys 308→ Arg 308 E2
Leu 28→ Phe 28 E5A
Val 41→ Leu 41 E5A
Table 2 Viral genome copy numbers in whole blood and
plasma
Patient specimen Viral genome copies/ml
Whole blood 8.85 × 105
Plasma fraction 1.55 × 106
Filtered plasma fraction 5.61 × 105
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marked cytological atypias (Figure 1D). In the left atrium,
a large thrombus was found (Figure 1E, F) behind a sessile
papillomatous lesion (Figure 1G), structurally, cytologic-
ally, and immunohistochemically identical to the tracheal
and pulmonary respiratory papillomas (Figure 1H). Immu-
nohistochemical examination revealed cytokeratin 5 and 6
expression in all neoplastic lesions indicating that the
lesion was of epithelial origin (Figure 2). Notably, no
lymph node or hematogenous metastases were found.
Molecular biological analyses revealed the presence of
HPV DNA in autoptic tissues of lung tumors and left
atrial papillomas. In addition, HPV DNA was detected
in the left atrial thrombus and the aorto-iliac throm-
boembolus. HPV-genotyping by nested multiplex PCR
[14] revealed strong bands specific for HPV6/11. In
order to distinguish between HPV6 and HPV11 DNA,
direct sequencing was performed (see Additional file 1)
demonstrating the exclusive presence of HPV11 in lung
tissue and atrial papillomas which was confirmed by
LiPa V2 genotyping as an independent method of HPV
detection.
Conclusion
JORRP is a rare disease which is typically diagnosed in
early childhood. It is thought to be caused by the HPV
types 6 and 11, which may have been vertically transmit-
ted to the child at birth. It usually affects the larynx, but
up to 5% of the patients show involvement of trachea
and bronchi and 1% of patients develop manifestations
within the lung parenchyma [1,2]. Rarely spontaneous
carcinomatous transformation occurs [3], but distant
metastases do not develop [2]. We here describe a 19-
year-old male patient with an aggressive form of JORRP
that required numerous interventions after diagnosis.Table 3 Viral particles are not present in the patient’s
plasma after treatment with Benzonase
Proteinase K Benzonase LiPa genotyping results
SiHa control + HPV16
SiHa control + + HPV-negative
SiHa control + HPV-negative
Plasma + HPV11
Plasma + + HPV-negative
Plasma + HPV-negativeScattered papillomas were found in the trachea, bronchi,
and both lungs. In multiple locations, bilateral malignant
transformation into well-differentiated squamous cell
carcinomas had occurred. HPV11 was detected in laryn-
geal biopsies at high viral load, suggestive of an on-going
productive infection. Moreover, HPV11 was detected in
autopsy material of the pulmonary squamous cell carcin-
omas, the left atrial papilloma, the left atrial thrombus,
and the thromboembolic material. The same HPV type
was isolated and cloned from the laryngeal biopsy. Se-
quencing of the patient’s HPV11 isolate showed that it is
99% identical to the HPV11 reference nucleotide sequence
[12]. It revealed 15 mutations previously observed in an
HPV11 isolate from a squamous cell carcinoma of the
penis [15,16].
HPV infections usually remain localised and viral par-
ticles are not shed into the blood stream. Interestingly
however, high viral genome copy numbers were detected
in the plasma fraction of the patient’s blood, but not in
the cellular fraction demonstrating that the viral genomes
were not cell associated. The increased number of viral
genomes detected within the plasma as compared to the
whole blood (Table 2) is explained by the exclusion of the
HPV-negative cellular fraction, which ultimately led to a
concentration of the remaining plasma fraction. In con-
nection with the high viral load within the serum, our
patient presented high antibody titres against the viral
structural protein L1. The antibody titre measured in the
2007 sample (Table 2) is one of the highest ever seen in
our laboratory, which usually processes samples from pa-
tients vaccinated with the quadrivalent vaccine against
HPV6, 11, 16 and 18. Interestingly, no antibodies against
the oncoproteins E6 and E7 were detected. A similar im-
mune response against the structural proteins of the virus
is typically induced by HPV vaccines or by viral particles
entering the blood stream, however, we were not able to
show the presence of viral particles within the patient’s
plasma. As HPV infections usually remain localised and
viral particles are not shed into the blood stream, we
hypothesise that a potential angioinvasion of the lung
squamous cell carcinoma may have provided a way which
enabled viral DNA to enter the blood stream. On another
note, it is possible that the high HPV DNA levels originate
from necrotic cells or thrombi shed from the endocardial
lesion and/or respiratory tumors. In a study from Maloney
et al., only 20% of the patients show detectable antibody
levels [17]. Interestingly, those three reported patients also
had the highest levels of HPV11 viral load and the highest
average numbers of annual surgical procedures. HPV
DNA has previously been detected within blood cells
of healthy individuals [18] and in the plasma of HIV-1
patients [19] and women with cervical cancer [20,21].
However, none of these studies examined the immune
response.
Figure 1 Post-mortem autopsy results. Laryngeal respiratory papillomas with focal squamous metaplasia (A); multiple nodules (B) of well
differentiated squamous cell carcinoma (C); shed tumor cells with marked cytologic atypia, reminiscent of respiratory papilloma (D); left atrial
thrombus (E) and thromboembolus riding on the aorto-iliacal bifurcation (F); area of endocardial papillomatosis in the left atrium (G, H) as the
basis for recurrent thrombosis.
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spread of the HPV infection was not contained by high
antibody titres directed against L1. Alternatively, spread
of infection might have occurred at a very early stage es-
pecially considering that multiple surgical interventions
might have increased the risk for tracheal and pulmon-
ary involvement. Viral DNA could therefore have per-
sisted for a considerable time before disease progression
and we speculate that a high antibody titre might reflectan increase in disease progression and an elevation of
productive infection within existing papillomas.
Post mortem examination revealed that descending
tracheobronchial respiratory papillomas had undergone
squamous metaplasia and subsequent malignant trans-
formation into well-differentiated squamous cell carcin-
omas. Based on the structural and cytological similarity,
including cytological atypia of the tracheobronchial,
pulmonary and atrial papillomatous lesions, we conclude
Figure 2 Immunohistochemical staining for the expression of cytokeratin 5/6, a typical marker of squamous epithelium, on a section
of a focal squamous papillary metaplasia of the left atrium.
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More importantly, these papillomatous lesions were the
source for the recurrent thromboembolic events (Figure 1F)
that had led to two episodes of Leriche’s syndrome and to
multiple ischemic infractions in various organs, including
spleen, kidneys, lower extremities, brain, and heart.
On the basis of the detection of HPV11 DNA in the
atrial papilloma, we demonstrated the presence of a very
rare endocardial papilloma [22]. To our knowledge this
is the first report of an HPV-induced endocardial papil-
loma as the source of fatal thromboembolic complications
during the course of canalicular disseminating HPV11-
associated longstanding JORRP disease with malignant
transformation into well-differentiated squamous cell car-
cinoma. In addition, this case is remarkable considering
the high levels of viral DNA detected within the patient’s
serum and the high immune response directed against the
viral structural surface protein L1. A humoral immune
response against structural proteins is outmost uncom-
mon in RRP patients and may in our case be explained by
the presence of productive papilloma tissue. In summary,
we here reported a severe case of JORRP hallmarked by
HPV11 DNAemia and very high L1-antibody titres. Fur-
thermore, our unusual and unexpected finding of the
extent of malignant transformation and the discovery of a
very rare fatal endocardial lesion highlight the unpre-
dictability of JORRP and the complexity of its clinical
management.
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